Current Sitting President

Julia A. Bridge, MD

Translational Genomics Research Institute / University of Nebraska Medical Center

Dr. Bridge is Professor at the Translational Genomics Research Institute (TGen)/Ashion (Director, Division of Molecular Pathology; Phoenix AZ) and the University of Nebraska Medical Center. Dr. Bridge earned her MD from the University of Nebraska Medical Center and completed her pathology residency at the University of Kansas Medical Center followed by clinical cytogenetic and molecular fellowships at the University of Nebraska Medical Center and the Southwest Biomedical Research Institute in Scottsdale Arizona. She is Past-President of the International Society for Bone and Soft Tissue Pathology. She serves or has served on editorial boards for pathology, orthopedic, and genetics journals, in consulting or advisory board positions for cancer networks and industry (including as key investigator for landmark FDA approvals for two novel gene-based tests), the national Children’s Oncology Group Soft Tissue Sarcoma and Ewing sarcoma committees, and Secretarial Appointee to the national Department of Veterans Affairs Genomic Medicine Program Advisory Committee. Dr. Bridge has been involved in USCAP in several capacities through teaching [short courses, long course, evening and companion courses as well as directing molecular special course, 14 years], moderating sessions, and committee/leadership appointments (Education Committee, USCAP Council, among others). She has published greater than 300 papers, chapters, review articles, digital and web-based materials, and is co-author or co-editor of several books (e.g. AFIP Atlas of Tumor Pathology; 4th Series, Fascicle 2: Tumors of the Bones and Joints and 4th edition of the WHO Classification of Tumours of Soft Tissue and Bone) and directs a research laboratory focused on molecular profiling of solid tumors and molecular test development. She is now the President of the United States and Canadian Academy of Pathology.